Publications

(2023). Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research, 42.

PDF Paper Link

(2023). Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin. Cancer Cell International, 23.

PDF Paper Link

(2023). MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition. Journal of Experimental & Clinical Cancer Research, 42.

PDF Paper Link

(2022). A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2. Molecular Therapy-Nucleic Acids, 27.

PDF Paper Link

(2022). α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer. Theranostics, 12.

PDF Paper Link

(2020). DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression. Theranostics, 10.

PDF Paper Link

(2019). A DNA Aptamer targeting galectin-1 as a novel immunotherapeutic strategy for lung cancer. Molecular Therapy-Nucleic Acids, 18.

PDF Paper Link

(2019). MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer. Oncogene, 39.

PDF Paper Link

(2016). CASZ1 is a novel promoter of metastasis in ovarian cancer. American journal of cancer research, 6.

PDF Paper Link